Efficacy of epidermal growth factor receptor tyrosine kinase inhibitor in the treatment of patients with nonsmall cell lung cancer

This study aimed to examine the effectiveness of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) in treating patients with nonsmall cell lung cancer (NSCLC), and the association between clinical characteristics and effectiveness. This retrospective study included 140 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xi, Li, Wen-Bo, Luo, Qiang, Liu, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519542/
https://www.ncbi.nlm.nih.gov/pubmed/37747005
http://dx.doi.org/10.1097/MD.0000000000035081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519542/
https://www.ncbi.nlm.nih.gov/pubmed/37747005
http://dx.doi.org/10.1097/MD.0000000000035081

Ejemplares similares